RESOURCES | BLOG

September 26, 2026

AI Cardiac Monitoring Remote Patient Care: A Practice Guide

Rhythm360 helps cardiology & EP programs implement AI cardiac monitoring RPM. Get the guide to optimize workflows, billing & patient outcomes.

Key Takeaways for Cardiology and EP Leaders

AI cardiac monitoring uses machine learning to ingest, normalize, and triage CIED data from multiple manufacturers, filtering non-actionable alerts before human review.
The complete workflow spans six stages: data ingestion, AI analysis, clinical review, escalation, billing documentation, and EHR integration. Each stage carries specific compliance requirements.
Fragmented OEM portals and high volumes of non-actionable transmissions create alert fatigue. Vendor-neutral platforms with AI triage reduce this burden while preserving clinical oversight.
Success depends on readiness across stakeholder alignment, workflow maturity, data quality, EHR integration, CPT documentation, and staff training. Gaps in any area can cause missed events and revenue leakage.
Rhythm360 consolidates data from all major manufacturers, applies AI-powered alert triage, supports CPT code capture, and provides bidirectional EHR integration in a single HIPAA-compliant platform.

See How Rhythm360 Fits Your Monitoring Workflow

Current Cardiac Remote Monitoring Landscape

The cardiac remote monitoring ecosystem spans multiple stakeholder groups. Clinical teams include electrophysiologists, cardiologists, PAs, NPs, RNs, and device technicians (CCTs). Device manufacturers include Medtronic, Boston Scientific, Abbott, and Biotronik. EHR vendors include Epic, Cerner, Athenahealth, eClinicalWorks, and Greenway Health. Billing requirements and payer policies add another layer of operational complexity.

Remote monitoring has received a Class I recommendation from the Heart Rhythm Society since 2015, and a 2024 real-world analysis of 26 centers found they reviewed over 70,000 remote transmissions in 2023, compared to just 6,600 in-office interrogations. Remote monitoring now functions as the primary device clinic workflow rather than a supplement to in-person care.

The structural challenge is fragmentation. Each major CIED manufacturer operates its own proprietary remote monitoring network: Medtronic CareLink, Boston Scientific LATITUDE, Abbott Merlin.net, and Biotronik Home Monitoring. No universal interoperability standard connects these networks. Practices that implant devices from more than one manufacturer must maintain separate portal logins, manual data transcription workflows, and disconnected alert queues. A 2023 study published in Pacing and Clinical Electrophysiology found that 73% of CIED alerts and 90% of scheduled transmissions were nonactionable. This volume creates alert fatigue and compounds the administrative burden of fragmented portals.

The market now favors integrated, AI-assisted, vendor-neutral models that consolidate data across manufacturers, apply machine learning to triage alerts, and connect bidirectionally with EHRs. Platform providers operating in this space include RhythmScience (Rhythm360) and other platforms. To understand how these platforms address fragmentation, it helps to trace the monitoring workflow step by step.

How AI Fits Into the Remote Monitoring Workflow

Remote patient monitoring using artificial intelligence applies machine learning at the data normalization and alert triage stages of the monitoring workflow. This approach reduces the volume of transmissions that require human review and surfaces clinically significant findings faster. The workflow follows six sequential steps:

Device Data Ingestion: CIEDs and remote physiologic monitors transmit data via manufacturer networks (Medtronic CareLink, Boston Scientific LATITUDE, Abbott Merlin.net, Biotronik Home Monitoring) or patient-facing apps.
Data Normalization: AI ingests and normalizes data from APIs, HL7, XML, and unstructured PDFs via computer vision (OCR). It fills gaps and flags connectivity issues.
AI Analysis and Alert Triage: Machine learning algorithms filter non-actionable transmissions and prioritize clinically significant events such as new-onset AFib, ventricular tachycardia, low battery indicators (ERI/RRT), and significant weight gain in HF patients. A 2026 study published in Sensors found that thresholding ensemble model predictions at a probability greater than 95% allowed AI to handle 91.9% of the total classification workload while making fewer than 0.1% errors. This result demonstrates the workload reduction potential of high-confidence AI triage.
Human Clinical Review: Clinicians review prioritized alerts, make diagnosis and treatment decisions, and document findings. AI prioritizes and filters alerts, while clinicians make the diagnosis, treatment decisions, and escalation calls.
Escalation and Intervention: Urgent findings follow a defined escalation protocol. Routine reports are batched and delivered on a predictable schedule.
Billing Documentation: Billable events are captured, CPT codes are assigned, and documentation flows to the EHR for claim submission.

University of Chicago Medicine reviewed more than 73,000 reports annually through its centralized, service-supported Rhythm360 monitoring program, averaging more than 18,000 reports per quarter. This experience shows how AI-assisted workflows scale in high-volume academic settings. As Andrew Beaser, MD, currently an Associate Professor of Medicine at the University of Chicago Medicine (UCM) specializing in cardiac electrophysiology, noted: "Decision support, including AI-assisted decision support, will become increasingly important as data volumes grow."

AI Cardiac Monitoring Devices and Data Sources

AI cardiac monitoring devices span several implantable and sensor categories. Each category generates distinct data types that feed into the monitoring workflow. Clear understanding of these categories supports correct CPT code selection and appropriate alert protocol design.

Each device category generates different data types and follows a different billing cycle, which shapes both the alert protocol and the CPT code you assign. The main CIED categories are:

Pacemakers: Track heart rate and pacing activity. Remote monitoring is billed on a 90-day cycle.
Implantable Cardioverter-Defibrillators (ICDs): Record arrhythmia episodes and delivered therapies. Monitoring also follows a 90-day cycle.
CRT/CCM Devices: Monitor pacing and heart failure indicators.
Implantable Loop Recorders (ILRs/ICMs): Provide long-term arrhythmia surveillance. Monitoring is billed on a 30-day cycle under CPT 93298.

Specialized sensors include CardioMEMS pulmonary artery monitors. These devices measure physiologic parameters such as pulmonary artery pressure to guide heart failure management and are billed under CPT 93297 on a 30-day cycle.

Medtronic states that today, millions of people implanted with heart devices are remotely monitored, confirming that CIED remote monitoring is a mature, high-volume standard of care. Each manufacturer ecosystem remains vendor-specific at the device and network layer. Vendor-neutral platforms therefore must ingest and normalize data from all major manufacturers to provide a unified clinical view. Rhythm360 consolidates data from Medtronic, Boston Scientific, Abbott, and Biotronik into a single dashboard. Clinicians no longer need separate portal logins.

Strategic Program Design Considerations

Organizations evaluating AI cardiac monitoring programs face several structural decisions. Leaders must choose centralization or decentralization of monitoring staff, build or buy for platform infrastructure, in-house or outsourced clinical oversight, and the level of integration with existing EHR environments.

A critical and frequently misunderstood boundary governs all of these decisions. The FDA classifies outpatient cardiac telemetry under product code QYX as a Class II device regulated under 21 CFR 870.1025, and the QYX classification explicitly states devices are "Not For Use For Detection Or Notification Of Hemodynamically Unstable Or Life-threatening Arrhythmias Or Cardiac Events Requiring Urgent Medical Response." AI cardiac monitoring functions as a surveillance and management tool, not an emergency-response system. Patients must receive clear education to seek emergency care for acute symptoms, and escalation protocols must reflect this regulatory boundary. Workflows that assume AI monitoring will substitute for emergency response create clinical and liability risk.

Governance and accountability also require attention. In its November 2025 science advisory published in Circulation, the American Heart Association raised concerns about AI in cardiovascular and stroke care, including variability in local validation, bias assessment, postdeployment monitoring, cybersecurity, and clinical accountability. Practices should address these concerns through vendor due diligence, staff training, and documented escalation protocols.

For practices that need vendor-neutral data consolidation, AI-powered alert triage, and CPT code capture in a single HIPAA-compliant platform, Rhythm360 provides bidirectional EHR integration and supports the full monitoring workflow from data ingestion through billing documentation.

Explore Rhythm360’s Data and Workflow Capabilities

Readiness and Implementation Considerations

Organizational readiness for AI cardiac monitoring spans six dimensions. These include stakeholder alignment among physicians, administrators, and IT; workflow maturity in existing device clinic processes; data quality and transmission reliability from enrolled devices; integration needs across EHR systems and OEM portals; compliance processes for CPT code documentation; and training requirements for clinical and administrative staff.

A functioning program needs electrophysiologists, cardiologists, PAs, NPs, RNs, device technicians (CCTs), and administrative staff for billing documentation. Because operational knowledge often concentrates in a single “super-user,” programs face business continuity risk when that person is unavailable. Rhythm360 reduces this dependency by providing a centralized, intuitive platform that distributes workflow access across roles.

Implementation timelines are shorter than many practices expect. Rhythm360 onboarding, including EHR integration, typically takes from a few days to a few weeks. UCM’s implementation of Rhythm360 enabled clinicians to review more transmissions daily and identify more abnormalities. The team noted, "We have improved billing and accountability for our patients after the integration."

Common Pitfalls and Risks

The most common implementation failures share a pattern. Organizations treat AI cardiac monitoring as a technology purchase and underinvest in workflow design, escalation protocol documentation, and change management.

Specific pitfalls include:

Fragmented Workflows: Retaining separate OEM portal logins alongside a new platform creates duplicate work and data reconciliation errors.
Unclear Ownership: Without defined roles for who reviews alerts, who escalates, and who signs reports, critical events fall through gaps.
Poor Alert Design: Overly broad alert thresholds generate non-actionable notifications that drive alert fatigue. Studies cited by AHRQ’s PSNet show that 80 to 99% of ECG monitor alarms are false or clinically insignificant, which illustrates how quickly poorly tuned alerts can overwhelm staff.
Weak Documentation: Missing signed reviews, incorrect device-type code assignments, and incomplete monitoring period logs are leading causes of CPT code claim denials.
Emergency-Response Misconception: The QYX boundary described earlier still applies. The FDA notes that these devices are not intended for patients who require prompt intervention for serious cardiovascular events. Practices that do not communicate this boundary to patients risk delayed emergency care for acute symptoms.
Misaligned Success Metrics: Measuring only transmission volume hides performance issues. Programs need visibility into critical alert response time, CPT code capture rate, and claim denial rate.

Measurement and Ongoing Optimization

Measurement provides the remedy for many of the pitfalls described above. A well-instrumented program measures performance across four categories, because clinical, operational, financial, and compliance signals each reveal different failure modes that a single metric would miss:

Clinical: Critical alert response times, patient device compliance rates, and event detection accuracy for conditions including new-onset AFib, ventricular tachycardia, ERI/RRT indicators, and HF weight gain thresholds.
Operational: Staff hours saved per week, alert triage accuracy, and workflow efficiency across the six-stage monitoring process.
Financial: CPT code capture rates by code and billing cycle, revenue recovery from previously unbilled technical components, and claim denial rates by denial reason.
Compliance: Auditable documentation completeness, HIPAA compliance status, and monitoring period continuity logs.

Practices implementing Rhythm360 have achieved up to an 80% reduction in critical alert response times and up to a 300% increase in revenue capture. Ongoing optimization requires periodic review of alert threshold settings, staffing assignments, EHR integration performance, and CPT code documentation workflows as patient volumes and CMS billing policies evolve.

Review Your Metrics with a Rhythm360 Specialist

Vendor Selection Framework for AI Cardiac Monitoring Remote Patient Care

Selecting the best remote monitoring software for a cardiology or EP program requires evaluating platforms on three primary dimensions:

Data Consolidation Capability: The platform should ingest and normalize data from all major device manufacturers, including Medtronic, Boston Scientific, Abbott, and Biotronik, without requiring separate OEM portal logins. It should also achieve reliable transmissibility across API, HL7, XML, and unstructured PDF data sources.
Alert Triage Quality: The AI triage layer should demonstrably reduce non-actionable alert volume while maintaining sensitivity for clinically significant events. A defined human review layer and configurable escalation protocol must align with the practice’s workflow.
EHR Integration Depth: The platform should support bidirectional data exchange, pulling discrete patient data from the EHR into the monitoring workflow and writing finalized reports, encounter data, and billing information back to the chart automatically.

Rhythm360 is a vendor-neutral, HIPAA-compliant platform that addresses all three dimensions. It ingests and normalizes data from Medtronic, Boston Scientific, Abbott, and Biotronik, provides AI-powered alert triage with optional 24/7/365 oversight by certified cardiac technicians (CCTs), supports CPT code capture across 90-day CIED cycles (93294, 93295, 93296) and 30-day monitor cycles (93297, 93298), and integrates bidirectionally with Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and others via HL7. Other platforms operating in this space include Murj, Implicity, Rhythm Management Group, and Octagos.

Frequently Asked Questions About AI Cardiac Monitoring and RPM Billing

What Are the CMS Guidelines for Remote Patient Monitoring?

Medicare generally restricts remote patient monitoring services to established patients with chronic conditions expected to last at least 12 months or until death and that place the patient at significant risk of death, acute exacerbation, or functional decline. Devices used for RPM must be FDA-defined medical devices capable of automatically collecting and transmitting patient data; devices that rely solely on manual patient entry typically do not qualify for reimbursement under current guidelines.

Documentation best practices include obtaining and recording explicit patient consent and documenting the date the RPM device was provided along with evidence of patient education. Teams should also maintain daily data transmission logs showing at least 16 days of data collection for CPT 99454, keep detailed clinical time logs for CPT 99457 and 99458, document the date and nature of interactive communications, and integrate RPM data reviews into the patient’s electronic health record. CMS National Coverage Determination 20.8.1 governs cardiac pacemaker evaluation services and assigns monitoring frequency decisions to the treating physician based on individual patient circumstances. Commercial payers may have varying policies, so providers must verify each payer’s specific requirements before initiating RPM services.

What Are the New CPT Codes for Remote Patient Monitoring in 2026?

For pacemakers and ICDs billed on a 90-day cycle, CPT 93294 covers professional interrogation services for pacemaker systems, CPT 93295 covers professional interrogation services for ICD systems, and CPT 93296 is the technical code for remote data acquisition and technician review for both pacemaker and ICD systems. These codes describe services furnished over the monitoring period rather than payment per individual transmission.

For physiologic monitors and loop recorders billed on a 30-day cycle, CPT 93297 applies to implantable cardiovascular physiologic monitors such as CardioMEMS, which measure parameters like pulmonary artery pressure. CPT 93298 applies to subcutaneous cardiac rhythm monitors and implantable loop recorders (ILRs/ICMs). These are device-specific codes, not a professional and technical pair. Each is billable once per 30-day period and can be billed global, with modifier -26 for the professional component, or with modifier -TC for the technical component.

For physiological monitoring of chronic conditions, CPT 99453 covers remote monitoring device setup and patient education, billed once per episode of care. CPT 99454 covers device supply with daily recording over a 30-day period, requiring at least 16 days of data collection. CPT 99457 covers the first 20 minutes of remote physiologic monitoring treatment management in a calendar month, requiring at least one interactive communication with the patient or caregiver.

CMS published a proposed rule for CY 2027 that includes refinements to RPM codes and solicits feedback on consolidating multiple RPM codes into new G-codes. Practices should monitor the CY 2027 Medicare Physician Fee Schedule final rule, expected near the start of November 2026, for changes that may affect documentation and billing workflows.

What Is the CMS 3-Day Rule and How Does It Affect Monitoring?

The CMS 3-day rule, also known as the 3-day payment window, relates to the bundling of outpatient services into a preceding inpatient admission. Under Medicare’s 3-day (or 1-day) payment window, the technical component of all outpatient diagnostic services and related non-diagnostic services furnished to a Medicare beneficiary within the 3 days (or 1 day for a non-subsection (d) hospital) preceding an inpatient admission are bundled into the inpatient payment rather than billed separately, in compliance with Section 1886 of the Social Security Act. For remote cardiac monitoring programs, practices should verify current CPT instructions, National Correct Coding Initiative (NCCI) edits, and payer-specific billing policies before reporting both remote and in-person device evaluation services during the same monitoring cycle, because bundling rules and NCCI edits can affect which codes are separately payable in a given period.

What Is One Disadvantage of Remote Patient Monitoring?

One significant disadvantage is that remote monitoring does not function as an emergency-response system. The FDA outpatient cardiac telemetry classification under product code QYX explicitly states devices are "Not For Use For Detection Or Notification Of Hemodynamically Unstable Or Life-threatening Arrhythmias Or Cardiac Events Requiring Urgent Medical Response." Patients must be educated at enrollment to seek emergency care immediately for acute symptoms such as chest pain, syncope, or severe dyspnea and to avoid waiting for a monitoring alert or clinician callback. Practices that fail to communicate this boundary clearly in patient education materials and consent documentation create clinical risk and potential liability exposure.

Which Companies Are Leading in Cardiac Remote Patient Monitoring?

Leading device manufacturers whose CIEDs generate the data that flows into remote monitoring platforms include Medtronic, Boston Scientific, Abbott, and Biotronik. Each operates its own proprietary remote monitoring network with no universal interoperability standard connecting them. Platform providers that consolidate data across manufacturers and support clinical workflow include RhythmScience (Rhythm360) and other platforms. Selection among platform providers should be based on data consolidation capability across all major manufacturers, alert triage quality and sensitivity for clinically significant events, EHR integration depth and bidirectionality, CPT code capture support, and HIPAA compliance.

Conclusion: Operational Lens for AI Cardiac Monitoring Remote Patient Care

AI cardiac monitoring remote patient care is a workflow, compliance, and reimbursement problem that often presents as a technology problem. Practices that evaluate it solely as a device or software purchase will encounter fragmented data and missed critical events. They will also leave monitoring cycles unbilled and burn out clinical staff.

The correct evaluation lens covers six dimensions: data consolidation across all major device manufacturers, AI alert triage quality and sensitivity, a defined human clinical review layer, a documented escalation protocol, billing compliance across the applicable CPT codes and monitoring cycles, and bidirectional EHR integration. These are distinct from the six readiness dimensions and six workflow stages described earlier.

Rhythm360 is built to address all six dimensions in a single vendor-neutral, HIPAA-compliant platform. The platform supports cardiology practices and health systems from solo EP clinics to academic medical centers managing tens of thousands of annual transmissions.

Talk with Rhythm360 About Your Monitoring Program